Search

Author/Creator Penson, Richard T.

1. A Phase II, Two-Stage Study of Letrozole and Abemaciclib in Estrogen Receptor–Positive Recurrent Endometrial Cancer. Issue 3 (29th September 2022)

Authors:
Konstantinopoulos, Panagiotis A.; Lee, Elizabeth K.; Xiong, Niya; Krasner, Carolyn; Campos, Susana; Kolin, David L.; Liu, Joyce F.; Horowitz, Neil; Wright, Alexi A.; Bouberhan, Sara; Penson, Richard T.; Yeku, Oladapo; Bowes, Brittany; Needham, Hope; Hayes, Martin; Sawyer, Hannah; Polak, Madeline;...
Journal:
Journal of clinical oncology
Issue:
Volume 41:Issue 3(2023)
Page Start:
599
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Olaparib Tablets as Maintenance Therapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a BRCA1/2 Mutation (SOLO2/ENGOT-Ov21): A Final Analysis of a Double-Blind, Randomised, Placebo-Controlled, Phase 3 Trial. Issue 9 (September 2021)

Authors:
Poveda, Andrés; Floquet, Anne; Ledermann, Jonathan A.; Asher, Rebecca; Penson, Richard T.; Oza, Amit M.; Korach, Jacob; Huzarski, Tomasz; Pignata, Sandro; Friedlander, Michael; Baldoni, Alessandra; Park-Simon, Tjoung-Won; Tamura, Kenji; Sonke, Gabe S.; Lisyanskaya, Alla; Kim, Jae-Hoon; Filho, Eli...
Journal:
Obstetrical & gynecological survey
Issue:
Volume 76:Issue 9(2021)
Page Start:
535
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Olaparib Tablets as Maintenance Therapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a BRCA1/2 Mutation (SOLO2/ENGOT-Ov21): A Final Analysis of a Double-Blind, Randomised, Placebo-Controlled, Phase 3 Trial. Issue 9 (September 2021)

Authors:
Poveda, Andrés; Floquet, Anne; Ledermann, Jonathan A.; Asher, Rebecca; Penson, Richard T.; Oza, Amit M.; Korach, Jacob; Huzarski, Tomasz; Pignata, Sandro; Friedlander, Michael; Baldoni, Alessandra; Park-Simon, Tjoung-Won; Tamura, Kenji; Sonke, Gabe S.; Lisyanskaya, Alla; Kim, Jae-Hoon; Filho, Eli...
Journal:
Obstetrical & gynecological survey
Issue:
Volume 76:Issue 9(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Phase 2 trial of aromatase inhibition with letrozole in patients with uterine leiomyosarcomas expressing estrogen and/or progesterone receptors. Issue 5 (12th November 2013)

Authors:
George, Suzanne; Feng, Yang; Manola, Judith; Nucci, Marisa R.; Butrynski, James E.; Morgan, Jeffrey A.; Ramaiya, Nikhil; Quek, Richard; Penson, Richard T.; Wagner, Andrew J.; Harmon, David; Demetri, George D.; Krasner, Carolyn
Journal:
Cancer
Issue:
Volume 120:Issue 5(2014)
Page Start:
738
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Phase 2 trial of aromatase inhibition with letrozole in patients with uterine leiomyosarcomas expressing estrogen and/or progesterone receptors. Issue 5 (12th November 2013)

Authors:
George, Suzanne; Feng, Yang; Manola, Judith; Nucci, Marisa R.; Butrynski, James E.; Morgan, Jeffrey A.; Ramaiya, Nikhil; Quek, Richard; Penson, Richard T.; Wagner, Andrew J.; Harmon, David; Demetri, George D.; Krasner, Carolyn
Journal:
Cancer
Issue:
Volume 120:Issue 5(2014)
Page Start:
738
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Phase II Activity of Belinostat (PXD-101), Carboplatin, and Paclitaxel in Women With Previously Treated Ovarian Cancer. Issue 6 (1st July 2012)

Authors:
Dizon, Don S.; Damstrup, Lars; Finkler, Neil J.; Lassen, Ulrik; Celano, Paul; Glasspool, Ros; Crowley, Elizabeth; Lichenstein, Henri S.; Knoblach, Poul; Penson, Richard T.
Journal:
International journal of gynecological cancer
Issue:
Volume 22:Issue 6(2012)
Page Start:
979
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗